Medicines Discovery Catapult

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Sustainability

UK Invests £9.9m to turn recycled nuclear material into lead-212 cancer therapies

A new UK-wide programme will use recycled nuclear fuel to create sustainable lead-212 targeted alpha therapies, aiming to deliver next-generation precision cancer treatments for hard-to-treat tumours
Research & Development

Medicines Discovery Catapult announces collaboration with £15.9m project on next-gen human disease modelling

The Medical Research Council, Wellcome Trust and Innovate UK will work with MDC to develop advanced, specific and highly reproducible human-based in vitro models of disease, with the aim of making them widely available to researchers in academia and industry
Research & Development

Medicines Discovery Catapult and Crown Bioscience forge global alliance to advance radiopharmaceutical innovation

The partnership will create an integrated translational biology platform to accelerate the development of next-generation radiopharmaceuticals for cancer diagnosis and treatment
Research & Development

Medicines Discovery Catapult and the Francis Crick Institute partner to delivery KQ Labs

The initiative helps biotech startups by offering mentoring, access to industry and investor networks, as well as drug development and translational support
Research & Development

Selvita acquires license for Medicines Discovery Catapult’s patented target engagement technology

The Chemical Protein Stability Assay generates vital data to support drug discovery innovators and will enhance Selvita’s screening platform
Manufacturing

Life sciences sector hit with funding cuts, but novel report highlights feasible industry solutions

The review highlights the recent investment reductions observed within the life sciences industry, and why its important to support smaller businesses to develop their innovations
Manufacturing

MDC and SMi secure grant to detect cancer biomarkers

It will transform their use for routine cancer screening and enable monitoring of treatment efficacy in real time
Subscribe now